ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Partner Therapeutics’ inhaled sargramostim improves lung function in trial
March 02, 2021Partner Therapeutics has reported positive top-line results from the investigator-led study of inhaled Leukine (sargramostim) in hospitalised Covid-19 patients. -
Partner Therapeutics Wins $35M DoD Contract for Leukine in COVID-19
August 05, 2020Funding will support two clinical trials in COVID-19 patients, expansion of manufacturing capacity and potential Emergency Use Authorization filing. -
Partner Therapeutics Announces Trial to Evaluate Leukine® for COVID-19 Respiratory Illness
March 30, 2020Partner Therapeutics announced Leukine® (sargramostim, rhu-GM-CSF) is being assessed in the SARPAC trial (sargramostim in patients with acute hypoxic respiratory failure due to COVID-19 – EudraCT #2020-001254-22).
Pharma Sources Insight January 2025
